BCL6 and B-cell non-Hodgkin lymphoma: Initially described as a proto-oncogene and transcriptional repressor implicated in the pathogenesis of B-cell lymphoma, BCL6 has recently been identified as a promising tissular biomarker which could be used to diagnose women affected by endometriosis [1,2,3,4].